Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Cognizant forecasts higher revenue growth as healthcare spending rises

Published 02/04/2015, 11:50 AM
Updated 02/04/2015, 11:50 AM
Cognizant forecasts higher revenue growth as healthcare spending rises

By Abhirup Roy

(Reuters) - Cognizant Technology Solutions Corp's fourth-quarter revenue rose more than expected and the IT services provider forecast a pick up in annual revenue growth as healthcare and financial services clients in North America boost spending.

The company shares rose as much as 7 percent to a record high of $58.94 on Wednesday.

Like its Indian rivals Tata Consultancy Services, and Infosys Ltd, Cognizant also gets the largest chunk of its revenue from financial services clients.

But the company's healthcare business, which accounts for about a quarter of revenue, was the fastest growing in the year ended December.

After slowing in the third quarter, growth in the business picked up in the fourth quarter, helping assuage concerns about spending by clients such as insurers, hospitals and state-run exchanges set up under the U.S. Affordable Care Act, or Obamacare.

That helped the company's total revenue rise a better-than-expected 16.4 percent to $2.74 billion in the quarter.

Robert W. Baird & Co analyst David Koning said organic constant currency revenue growth was about 14 percent, the company's strongest acceleration in over four years.

"The core business in healthcare seems to be getting better again and we heard competitors also say financial services and healthcare are doing quite well," Koning said. "So, I think that's what's setting up a really nice growth pattern."

Cognizant, which gets nearly 80 percent of revenue from North America but has most of its employees in India, forecast 2015 revenue growth of at least 19 percent.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

That was higher than the 16.1 percent achieved in 2014, the lowest in the Teaneck, New Jersey-based company's 20-year history.

"We think there are significant opportunities in the healthcare space in the next several years, particularly here in the United States with the continued implementation of the Affordable Care Act," Chief Financial Officer Karen McLoughlin told Reuters.

Revenue in Cognizant's healthcare business grew 26 percent in the fourth quarter, boosted by the $2.7 billion acquisition of TriZetto Corp in the quarter.

Excluding TriZetto, the company's biggest deal ever, healthcare revenue grew 15.2 percent, which was still the highest among its major businesses.

Profit rose 11.9 percent to $362.9 million, or 59 cents per share. Excluding items, the company earned 67 cents per share, beating analysts estimates of 65 cents per share.

Through Tuesday, Cognizant's stock had risen 10 percent since Aug. 6 when the company warned of slowing revenue growth.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.